4//SEC Filing
Howton David T 4
Accession 0000950170-23-068067
CIK 0001707502other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 2:32 PM ET
Size
8.6 KB
Accession
0000950170-23-068067
Insider Transaction Report
Form 4
Howton David T
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2023-12-02+13,051→ 13,051 total - Sale
Common Stock
2023-12-04$2.78/sh−5,367$14,920→ 7,684 total - Exercise/Conversion
Restricted Stock Units
2023-12-02−13,051→ 39,154 total→ Common Stock (13,051 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").
- [F2]This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).
- [F3]The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.
Documents
Issuer
Solid Biosciences Inc.
CIK 0001707502
Entity typeother
Related Parties
1- filerCIK 0001529297
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 2:32 PM ET
- Size
- 8.6 KB